FIBROGEN INC Uncategorized Contracts & Agreements
19 Contracts & Agreements
- First Amended and Restated Evaluation Agreement by and between FibroGen, Inc. and Fortis Therapeutics, Inc., dated June 6, 2024 (Filed With SEC on August 6, 2024)
- Offer Letter by and between FibroGen, Inc. and Deyaa Adib, M.D., dated February 6, 2024 (Filed With SEC on May 6, 2024)
- Offer Letter, dated July 23, 2023, between FibroGen, Inc. and Thane Wettig (Filed With SEC on July 25, 2023)
- Offer Letter by and between FibroGen, Inc. and Juan Graham, effective as of July 30, 2021 (Filed With SEC on November 9, 2021)
- Offer Letter, by and between FibroGen, Inc. and Mark Eisner, dated as of October 22, 2020 (Filed With SEC on March 1, 2021)
- Product Specific Agreement by and between FibroGen, Inc. and Samsung Biologics Co., Ltd., effective as of October 30, 2020 (Filed With SEC on March 1, 2021)
- Offer Letter, by and between FibroGen, Inc. and Thane Wettig, dated as of May 7, 2020 (Filed With SEC on August 6, 2020)
- Offer Letter, by and between FibroGen, Inc. and Enrique Conterno, dated as of December 17, 2019 (Filed With SEC on March 2, 2020)
- Offer Letter, by and between FibroGen, Inc. and Elias Kouchakji, dated as of January 24, 2014 (Filed With SEC on March 2, 2020)
- Offer Letter, by and between FibroGen, Inc. and Christine Chung, dated as of June 17, 2008 (Filed With SEC on March 2, 2020)
- Offer Letter, by and between FibroGen, Inc. and James Schoeneck, dated September 18, 2019 (Filed With SEC on November 12, 2019)
- Preapproval Transfer Price Letter to Astellas Pharma Inc., dated June 15, 2018 (Filed With SEC on August 7, 2018)
- Materials Transfer Agreement Letter to Astellas Pharma Inc., dated June 15, 2018 (Filed With SEC on August 7, 2018)
- Exhibit A Work Scope [*] (Version of August 31, 2016) [*] (Filed With SEC on November 8, 2016)
- Exhibit A Work Scope [*] (Version of June 8, 2016) [*] (Filed With SEC on November 8, 2016)
- FIBROGEN INCENTIVECOMPENSATION PLAN (Filed With SEC on June 10, 2016)
- Page 1 / 3 (Filed With SEC on November 12, 2015)
- FIBROGEN 2014 INCENTIVECOMPENSATION PLAN (Filed With SEC on October 30, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on October 23, 2014)
